Support for a TAVR-first approach in patients with concurrent valve and coronary disease
Findings support emphasis on markers of frailty related to, but not dependent on, age
Five-year data demonstrate convergence of outcomes from years 1 to 5
Randomized WATCH-TAVR trial confirms safety of the combined procedures
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New findings on aortic root position and features may lead to safer valvar surgery
Potential benefits include clinical guidance, TAVR outcome prediction, device testing
Choice between smaller or larger prosthesis is a tradeoff between leak and pacemaker risks
Results from largest randomized trial of the technology to date
Study offers guidance on an increasingly common presentation
How and why we are replicating our TAVR protocol across our U.S. and international sites